Trial Profile
SONATINA: A Phase II Multi-Centre Randomised Controlled Study of Nelfinavir Addition to Radiotherapy Treatment in Neo-Adjuvant Therapy for Rectal Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2014
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary)
- Indications Rectal cancer
- Focus Adverse reactions; Pharmacodynamics
- Acronyms SONATINA
- 17 May 2014 Trial status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 24 Jun 2011 New trial record